Across TCGA pan-cancer cohorts, C1QL4 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated C1QL4 data layer compared with 22 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher C1QL4 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated C1QL4 expression acts as an unfavorable survival marker.

STAD, BLCA, and LUAD are the cancer types where C1QL4 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	All	0.187	0.688	.008	12	view →
BLCA	DFS	Median	III,IV	0.025	0.572	<.001	6	view →
LUAD	OS	Median	All	0.237	0.788	.008	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: C1QL4 tumor-vs-normal RNA expression · all C1QL4 data types